 Home > Medical News > Medicines Company News > Duality Biologics completes US$90 million in Series B financing

Duality Biologics completes US$90 million in Series B financing

 Last Update: 2021-07-06
 Source: Internet
 Author: User

Tags

crestor drug class

king

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Duality Biologics, an innovative biopharmaceutical company, announced the completion of a US$90 million Series B financing
.

This round of financing was led by Eli Lilly Asia Fund (LAV), with joint participation of well-known domestic funds such as Coupled Health Fund, Huagai Capital, Newly Capital, Songhe Capital, and Yuanhe Holdings.

Develop novel modality drugs to meet the needs of patients

Focusing on the field of tumors and autoimmune diseases, Yingen Biotech has created a product pipeline with synergistic effects based on the urgent medical needs to be met, including nearly 10 Best-in-class and First-in-class bispecific antibodies and antibodies Conjugated drugs (ADC)
.

The company has successfully established a next-generation ADC platform with global intellectual property rights, and the value of the platform has been verified on a number of drug molecules under development

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.